Mice co-administrated with partially hydrolysed whey proteins and prebiotic fibre mixtures show allergen-specific tolerance and a modulated gut microbiota

Autor: Kleinjans, L, Veening-Griffioen, D H, Wehkamp, T, van Bergenhenegouwen, J, Knol, J, Garssen, J, Knippels, L M J, Belzer, C, Jeurink, P V, Pharmaceutics, Pharmacology, Afd Pharmaceutics, Afd Pharmacology

Publikováno v: Beneficial Microbes, 10(2), 165-178
Beneficial microbes, 10(2), 165. Wageningen Academic Publishers
Beneficial Microbes 10 (2019) 2

Non-breastfed infants at-risk of allergy are recommended to use a hydrolysed formula before the age of 6 months. The addition of prebiotics to this formula may reduce the allergy development in these infants, but clinical evidence is still inconclusi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbc028893f66b8c1121a8b5fa410b8b3
https://dspace.library.uu.nl/handle/1874/428162

Hesperidin reduces serum levels of triglyceride after coronary artery bypass graft surgery.

Autor: Booyani, Zahra¹ (AUTHOR), Aryaeian, Naheed¹ (AUTHOR) aryaeian.n@iums.ac.ir, Omidi, Negar² (AUTHOR) negar.omidi@gmail.com, Khorasanian, Atie Sadat¹ (AUTHOR), Hoseini, Agha Fatemeh³ (AUTHOR), Nejatian, Mostafa⁴ (AUTHOR), Jazayeri, Shima¹ (AUTHOR), Morvaridi, Mehrnaz¹ (AUTHOR)

Publikováno v: Food Science & Nutrition. Nov2023, Vol. 11 Issue 11, p7145-7154. 10p.

Structural Aspects of Antioxidant Activity of Flavonoids

Autor: Acker, S. A. B. E. Van, Berg, D.-J. Van Den, Tromp, M. N. J. L., Griffioen, D. H., Bennekom, W. P. Van, Vijgh, W. J. F. Van Der, Bast, A.

Publikováno v: Free Radical Biology & Medicine; 1996, Vol. 20 Issue: 3 p331-342, 12p

Effects of dihydrolipoic acid on peptide methionine sulfoxide reductase: Implications for antioxidant drugs

Autor: Biewenga, G. Ph, Veening-Griffioen, D. H., Nicastia, A. J., Guido Haenen, Bast, A.

Publikováno v: Scopus-Elsevier

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::667767cf0bd93dd01c480b9b475fd87e
http://www.scopus.com/inward/record.url?eid=2-s2.0-0031909323&partnerID=MN8TOARS

Predictive validity in drug discovery: what it is, why it matters and how to improve it.

Autor: Scannell JW; Science, Technology, and Innovation Studies, University of Edinburgh, Edinburgh, UK. jack.scannell@btinternet.com.; JW Scannell Analytics Ltd, Edinburgh, UK. jack.scannell@btinternet.com., Bosley J; NovaDiscovery SA, Lyon, France., Hickman JA; School of Biological Sciences, Manchester University, Manchester, UK., Dawson GR; P1vital Ltd, Wallingford, UK., Truebel H; The Knowledge House GmbH, Dusseldorf, Germany., Ferreira GS; 3D-PharmXchange, Tilden, Netherlands., Richards D; Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Treherne JM; Talisman Therapeutics Ltd, Cambridge, UK.

Publikováno v: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2022 Dec; Vol. 21 (12), pp. 915-931. Date of Electronic Publication: 2022 Oct 04.